Pietro Ameri

Dec 7, 2023 | onlinelibrary.wiley.com | Teresa López-Fernández |Dimitrios Farmakis |Pietro Ameri |Riccardo Asteggiano

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/ejhf.3102. The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

Mar 4, 2023 | jhltonline.org | Davide Stolfo |Davide Barbisan |Pietro Ameri

Risk scores are important tools for the prognostic stratification of pulmonary arterial hypertension (PAH). Their performance and the additional impact of comorbidities across age groups is unknown. Patients with PAH enrolled from 2001 to 2021 were divided in ≥65 years old vs <65 years old patients. Study outcome was 5-year all-cause mortality. FPHN, FPHN non-invasive, COMPERA and REVEAL 2.0 risk scores were calculated and patients categorized at low, intermediate and high risk.